Skip to main content
Fig. 1 | Journal of Intensive Care

Fig. 1

From: Effects of dexamethasone on immune dysfunction and ventilator-associated pneumonia in COVID-19 acute respiratory distress syndrome: an observational study

Fig. 1

Temperature, monocyte HLA-DR expression and lymphocytes count over time in COVID-19 patients with ARDS treated or not with dexamethasone. Individual (circles) and median (black hyphen) values of highest body temperature of the day (A), monocyte HLA-DR expression (mHLA-DR) expressed as numbers of antibodies bound per cells (AB/C), B), total lymphocytes count (C), and number of CD4 + lymphocytes (D) are reported at day 1, 3, 7 after admission for 18 patients with COVID-19-induced with ARDS during the first wave of the pandemic (blue circle) who did not receive dexamethasone and for 18 patients of the second wave treated with dexamethasone (orange circle). Empty circles indicate patients receiving invasive mechanical ventilation and full circles patients not intubated. Red dashed line indicates lower normal values for mHLA-DR and lymphocytes counts. *p < 0.05; **p < 0.01; ***p < 0.001 in two-way ANOVA with repeated measures

Back to article page